Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Osivax pivots to combo approach after flu jab fails in Phase 2b

Osivax’s lead flu vaccine has flopped in a mid-stage trial. But the French biotech still holds out hope for the program, and plans to combine it with existing flu shots. The Phase 2b trial aimed ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 15 October →